Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
LOI, Sherene, SIRTAINE, Nicolas, DE AZAMBUJA, Evandro, QUINAUX, Emmanuel, DI LEO, Angelo, MICHIELS, Stefan, PICCART, Martine J, SOTIRIOU, Christos, PIETTE, Fanny, SALGADO, Roberto, VIALE, Giuseppe, VAN EENOO, Françoise, ROUAS, Ghizlane, FRANCIS, Prudence, CROWN, John P. A, HITRE, Erika
Published in Journal of clinical oncology (01.03.2013)
Published in Journal of clinical oncology (01.03.2013)
Get full text
Journal Article
effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial
de Azambuja, Evandro, McCaskill-Stevens, Worta, Francis, Prudence, Quinaux, Emmanuel, Crown, John P. A, Vicente, Malou, Giuliani, Rosa, Nordenskjöld, Bo, Gutiérez, Jorge, Andersson, Michael, Vila, Mireia Margeli, Jakesz, Raimund, Demol, Jan, Dewar, Joanna, Santoro, Armando, Lluch, Ana, Olsen, Steven, Gelber, Richard D, Di Leo, Angelo, Piccart-Gebhart, Martine
Published in Breast cancer research and treatment (01.01.2010)
Published in Breast cancer research and treatment (01.01.2010)
Get full text
Journal Article
p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial
Sonnenblick, Amir, Salgado, Roberto, Brohée, Sylvain, Zahavi, Tamar, Peretz, Tamar, Van den Eynden, Gert, Rouas, Ghizlane, Salmon, Asher, Francis, Prudence A, Di Leo, Angelo, Crown, John P A, Viale, Giuseppe, Daly, Laura, Javdan, Bahar, Fujisawa, Sho, De Azambuja, Evandro, Lieveke, Ameye, Piccart, Martine J, Bromberg, Jacqueline F, Sotiriou, Christos
Published in International journal of oncology (01.02.2018)
Published in International journal of oncology (01.02.2018)
Get full text
Journal Article
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report
Reichman, B S, Seidman, A D, Crown, J P, Heelan, R, Yao, T J, Hakes, T B, Lebwohl, D E, Gilewski, T A, Surbone, A, Currie, V
Published in Annals of the New York Academy of Sciences (30.11.1993)
Published in Annals of the New York Academy of Sciences (30.11.1993)
Get more information
Journal Article